Andrew Wang, MD, Professor and Vice Chair of Translational Research & Commercialization, has received a multimillion-dollar RO1 grant to apply advances in tissue engineering to address the need for the development of cancer metastasis model that can reflect in vivo biology. Their goal is to engineer a cancer metastasis model that mimics human cancer metastasis pattern. Congratulations, Dr. Wang!
UT Southwestern Radiation Oncology
Hospitals and Health Care
Dallas, Texas 2,295 followers
The Department of Radiation Oncology at UTSW offers state-of-the-art radiation technology.
About us
The mission of our Department is three-fold: to deliver world-class care on a daily basis to our patients using the most advanced technologies available; to conduct groundbreaking basic, translational and clinical research; and to provide quality education to the next generation of medical practitioners and scientists. Our doctors, physicists, and researchers have devoted their lives to better understanding cancer and its treatment. Noted for groundbreaking research by our internationally recognized team, we deliver state-of-the art care to patients with all types and all stages of cancer. We are the only National Cancer Institute-designated comprehensive cancer center in North Texas and one of only 51 NCI-designated comprehensive care centers in the nation. As such, we are held to the highest of standards and are recognized for excellence in clinical care, as well as scientific research and leadership. In addition, we are one of the largest practices in the Southwest.
- Website
-
https://www.utsouthwestern.edu/education/medical-school/departments/radiation-oncology/
External link for UT Southwestern Radiation Oncology
- Industry
- Hospitals and Health Care
- Company size
- 201-500 employees
- Headquarters
- Dallas, Texas
- Founded
- 1995
- Specialties
- Radiation Oncology, Physics, Molecular Radiation Biology, Radiation Therapy, Adaptive Radiation Therapy, Cancer Treatment, Radiation Oncology Residency, and Medical Physics Residency
Updates
-
Beichuan Deng, Ph.D., gave an invited talk at The University of Texas at Dallas' Physics Colloquium. His talk was titled, "Self-supervised hybrid neural network to achieve quantitative bioluminescence tomography for cancer research." Dr. Deng is a postdoctoral researcher in the BIRTLab, which is led by Ken Kang-Hsin Wang, Ph.D.
-
-
Dr. Mu-han Lin, Associate Professor and Director of Adaptive Therapy in Medical Physics, had an article, "Safe Hypofractionation Amid Diverse Technologies: Using Teamwork to Manage the Complexity," published in Seminars in Radiation Oncology. Co-authors to this invited editorial about teamwork for SAbR implementation include Dr. Mona Arbab, Dr. Arnold Pompos, LaChandra Wilcox, Dr. Sepeadeh Radpour, Kajal Desai and Dr. Robert Timmerman. https://lnkd.in/gKZcSnCV Great work, team! (Images shown in order of names.)
-
-
Kai Jiang, Ph.D., DABR, has joined our faculty in the Division of Medical Physics and Engineering. Dr. Jiang earned his Ph.D. from Case Western Reserve University and subsequently completed a research fellowship at the Mayo Clinic. He went on to complete his #medphys residency at the University of Maryland, where he later served as a faculty #physicist. In his new role, Dr. Jiang will be the lead physicist at the Veterinary Research and Oncology Clinic (VROC). He will also contribute his expertise in our clinic and provide physics support to the Preclinical Radiation Core Facility. Welcome to Radiation Oncology, Dr. Jiang!
-
-
We are currently accepting applications for our two-year Medical Physics Adaptive Radiotherapy (MPART) Fellowship. This fellowship provides an opportunity for highly motivated and qualified individuals to further their training and experience in adaptive #radiotherapy #physics, with specific focuses on CT/CBCT-, MR-, and molecular imaging-guided RT and ART. The MPART Fellowship is designed to provide comprehensive clinical and research training in adaptive radiotherapy physics. Fellows will have the opportunity to rotate through our Ethos, Unity, and RefleXion services and work closely with our experienced faculty members. Fellows will gain hands-on experience in all aspects of ART treatment, including treatment planning, plan execution, and quality assurance. We welcome applications from both domestic and international applicants for this position. For more information or to apply, please email Kiera Smith at [email protected]. To apply, please include CV, personal statement, transcripts and/or proof of completion of residency or M.S./Ph.D./certificate program; three letters of recommendation.
-
-
Luiza Giuliani Schmitt, M.D., a senior research associate in Dr. Michael Dohopolski's lab, was one of ten recipients of the inaugural ASTRO-BCRF Trainee Travel Award, which is funded by The Breast Cancer Research Foundation (BCRF). Congratulations, Dr. Schmitt!
-
-
Welcome to Lena Jacob, PA-C, who has joined our lymphoma disease-oriented team. Lena earned her bachelor’s degree from Baylor University and her master’s degree from the University of North Texas Health Science Center. She completed her Master of Physician Assistant Studies from Massachusetts College of Pharmacy and Health Sciences (MCPHS) in Boston. Prior to joining our department, Lena was at the University of Texas MD Anderson Cancer Center Stem Cell Department.
-
-
Jef De Brabander, Ph.D., FAAAS, Professor, has joined us as faculty in the Section of Molecular Medicine. Dr. De Brabander earned his bachelor’s degree and Ph.D. from the University of Gent, Belgium, followed by postdoctoral research at both the University of Geneva and at Stanford University. Dr. De Brabander is an elected Fellow of the American Association for the Advancement of Science (FAAAS) and holds the Julie and Louis Beecherl, Jr., Chair in Medical Science. Prior to joining our department, Dr. De Brabander was part of the Department of Biochemistry at UT Southwestern. Welcome to Rad Onc, Dr. De Brabander!
-
-
Neil Desai, M.D., Associate Professor and Director of Clinical Research in the Department of Radiation Oncology, and a Dedman Family Scholar in Clinical Care, has received a Cancer Prevention and Research Institute of Texas (CPRIT) award totaling $1,460,229. This award will support #clinicaltrials aimed at adapting #radiotherapy to treatment response, as well as artificial intelligence innovations. https://lnkd.in/gyQDS2au Congratulations, Dr. Desai!
-
-
Arnold Pompos, Ph.D., was an invited panelist at last week's World Forum on Particle Therapy in Krems, Austria. His talk was titled "How can we optimize and innovate the delivery of particles."
-